M&A Deal Summary |
|
|---|---|
| Date | 2019-11-29 |
| Target | Grupo Biotoscana |
| Sector | Life Science |
| Buyer(s) | Knight |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2013 |
| Sector | Life Science |
| Employees | 745 |
| Revenue | 371M CAD (2024) |
Knight is a biopharmaceutical group that operates in the fast-growing Latin American region and focuses on rapidly growing market segments such as infectious diseases, oncology and onco-hematology, special treatments, immunology and inflammation, and orphan/rare diseases, among others. Knight was founded in 2013 and is based in Montreal, Quebec.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 3 |
| Sector: Life Science M&A | 2 of 3 |
| Type: Add-on Acquisition M&A Deals | 1 of 2 |
| Country: Uruguay M&A | 2 of 3 |
| Year: 2019 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-10-21 |
Grupo Farmaceutico Biotoscana
Montevideo, Uruguay Grupo Farmaceutico Biotoscana is a biopharmaceutical group that focuses on rapidly growing market segments such as infectious diseases, oncology and onco-hematology, special treatments, immunology and inflammation, and orphan/rare diseases, among others. Grupo Farmaceutico Biotoscana was formed in 1994 and is based in Montevideo, Uruguay. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-08-14 |
Grupo Farmaceutico Biotoscana
Montevideo, Uruguay Grupo Farmaceutico Biotoscana is a biopharmaceutical group that focuses on rapidly growing market segments such as infectious diseases, oncology and onco-hematology, special treatments, immunology and inflammation, and orphan/rare diseases, among others. Grupo Farmaceutico Biotoscana was formed in 1994 and is based in Montevideo, Uruguay. |
Sell | R$518M |
